title: Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
abstract: Sleeping Beauty (SB) transposon-mediated integration has been shown to achieve long-term transgene expression in a wide range of host cells. In this study, we improved the SB transposon-mediated gene transfer system for transduction of human CD34(+) stem/progenitor cells by two approaches: (1) to increase the transposition efficacy, a hyperactive mutant of SB, HSB, was used; (2) to improve the expression of the SB transposase and the transgene cassette carried by the transposon, different viral and cellular promoters were evaluated. SB components were delivered in trans into the target cells by Nucleoporation. The SB transposon-mediated integration efficacy was assessed by integrated transgene (enhanced green fluorescent protein [eGFP]) expression both in vitro and in vivo. In purified human cord blood CD34(+) cells, HSB achieved long-term transgene expression in nearly 7-fold more cells than the original SB transposase. Significantly brighter levels of eGFP expression (5-fold) were achieved with the human elongation factor 1alpha (EF1-alpha) promoter in Jurkat human T cells, compared with that achieved with the modified myeloproliferative sarcoma virus long terminal repeat enhancer-promoter (MNDU3); in contrast, the MNDU3 promoter expressed eGFP at the highest level in K-562 myeloid cells. In human CD34(+) cord blood cells studied under conditions directing myeloid differentiation, the highest transgene integration and expression were achieved using the EF1-alpha promoter to express the SB transposase combined with the MNDU3 promoter to express the eGFP reporter. Stable transgene expression was achieved at levels up to 27% for more than 4 weeks of culture after improved gene transfer to CD34(+) cells (average, 17%; n = 4). In vivo studies evaluating engraftment and differentiation of the SB-modified human CD34(+) cells demonstrated that SB-modified human CD34(+) cells engrafted in NOD/SCID/gamma chain(null) (NSG) mice and differentiated into multilineage cell types with eGFP expression. More importantly, secondary transplantation studies demonstrated that the integrated transgene was stably expressed in more primitive CD34(+) hematopoietic stem cells (HSCs) with long-term repopulating capability. This study demonstrates that an improved HSB gene transfer system can stably integrate genes into primitive human HSCs while maintaining the pluripotency of the stem cells, which shows promise for further advancement of non-virus-based gene therapy using hematopoietic stem cells.
authors.affiliation: Division of Research Immunology/Bone Marrow Transplantation, Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.
authors.forename: Teiko
authors.initials: T
authors.lastname: Sumiyoshi
authors.forename: Nathalia G
authors.initials: NG
authors.lastname: Holt
authors.forename: Roger P
authors.initials: RP
authors.lastname: Hollis
authors.forename: Shundi
authors.initials: S
authors.lastname: Ge
authors.forename: Paula M
authors.initials: PM
authors.lastname: Cannon
authors.forename: Gay M
authors.initials: GM
authors.lastname: Crooks
authors.forename: Donald B
authors.initials: DB
authors.lastname: Kohn
mesh_terms: D000818:Animals; D018952:Antigens, CD34 / Q000276:immunology; D002469:Cell Separation; D004251:DNA Transposable Elements; D005312:Fetal Blood / Q000166:cytology; D015870:Gene Expression; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D049452:Green Fluorescent Proteins / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006801:Humans; D019169:Jurkat Cells; D051379:Mice; D016513:Mice, SCID; D019076:Transgenes; D019895:Transposases / Q000235:genetics*
chemical_list: D018952:Antigens, CD34; D004251:DNA Transposable Elements; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D019895:Transposases; C494471:sleeping beauty transposase, human
references.citation: Lab Invest. 1993 Jun;68(6):676-86
references.pmid: 8515654
references.citation: Stem Cells. 2001;19(6):492-9
references.pmid: 11713340
references.citation: J Clin Invest. 2000 Apr;105(7):1013-21
references.pmid: 10749580
references.citation: Blood. 1995 Nov 15;86(10):3745-53
references.pmid: 7579341
references.citation: Blood. 2009 Aug 13;114(7):1319-30
references.pmid: 19414858
references.citation: Nat Protoc. 2007;2(7):1692-704
references.pmid: 17641634
references.citation: Mol Ther. 2008 Feb;16(2):359-69
references.pmid: 18071335
references.citation: J Biol Chem. 1989 Apr 5;264(10):5791-8
references.pmid: 2564392
references.citation: Mol Ther. 2007 Jan;15(1):139-45
references.pmid: 17164785
references.citation: Mol Ther. 2000 Nov;2(5):458-69
references.pmid: 11082319
references.citation: Mol Ther. 2007 Jan;15(1):10-2
references.pmid: 17164769
references.citation: Nat Med. 2006 Apr;12(4):401-9
references.pmid: 16582916
references.citation: Nat Biotechnol. 2005 Aug;23(8):967-73
references.pmid: 16082368
references.citation: Stem Cells Dev. 2006 Apr;15(2):278-85
references.pmid: 16646674
references.citation: Bone Marrow Transplant. 2001 Jun;27(11):1201-9
references.pmid: 11551032
references.citation: Mol Ther. 2004 Feb;9(2):147-56
references.pmid: 14759798
references.citation: Mol Ther. 2003 Jan;7(1):112-21
references.pmid: 12573624
references.citation: Exp Hematol. 1999 Jun;27(6):1019-28
references.pmid: 10378891
references.citation: Nat Genet. 2000 May;25(1):35-41
references.pmid: 10802653
references.citation: Transgenic Res. 1999 Jun;8(3):223-35
references.pmid: 10478492
references.citation: J Virol. 2004 Jun;78(12):6556-66
references.pmid: 15163748
references.citation: Mol Cell Biol. 2007 Mar;27(6):2048-58
references.pmid: 17242210
references.citation: Dev Biol. 1992 Oct;153(2):396-401
references.pmid: 1383066
references.citation: Stem Cells. 2008 Jun;26(6):1436-43
references.pmid: 18323409
references.citation: J Virol. 1996 May;70(5):3207-14
references.pmid: 8627801
references.citation: Science. 1999 Jan 29;283(5402):682-6
references.pmid: 9924027
references.citation: J Mol Biol. 2002 May 17;318(5):1221-35
references.pmid: 12083513
references.citation: Mol Ther. 2008 Mar;16(3):439-49
references.pmid: 18227842
references.citation: Blood. 2005 Sep 1;106(5):1565-73
references.pmid: 15920010
references.citation: J Mol Biol. 2005 Feb 11;346(1):161-73
references.pmid: 15663935
references.citation: Nat Biotechnol. 2007 Nov;25(11):1298-306
references.pmid: 17965707
references.citation: Blood. 2002 Nov 1;100(9):3175-82
references.pmid: 12384415
references.citation: J Mol Biol. 2000 Sep 8;302(1):93-102
references.pmid: 10964563
references.citation: Cell. 1997 Nov 14;91(4):501-10
references.pmid: 9390559
references.citation: Mol Ther. 2006 Oct;14(4):505-13
references.pmid: 16905365
references.citation: Gene Ther. 2009 Jun;16(6):724-33
references.pmid: 19262614
references.citation: Science. 2002 Jun 28;296(5577):2410-3
references.pmid: 12089448
references.citation: Methods Mol Biol. 2008;435:165-73
references.pmid: 18370075
references.citation: Blood. 2006 Jan 15;107(2):483-91
references.pmid: 16189271
references.citation: J Neurosci Res. 2009 Jan;87(1):289-300
references.pmid: 18756516
references.citation: N Engl J Med. 2009 Jan 29;360(5):518-21
references.pmid: 19179320
references.citation: Genetica. 1997;100(1-3):177-84
references.pmid: 9440271
references.citation: J Virol. 2003 Sep;77(17):9439-50
references.pmid: 12915559
references.citation: Gene Ther. 1999 May;6(5):715-28
references.pmid: 10505094
references.citation: Curr Opin Pharmacol. 2005 Oct;5(5):513-9
references.pmid: 16084771
references.citation: IUBMB Life. 2007 Jun;59(6):374-9
references.pmid: 17613167
references.citation: Nucleic Acids Res. 1990 Sep 11;18(17):5322
references.pmid: 1698283
references.citation: Mol Ther. 2002 Nov;6(5):615-26
references.pmid: 12409260
references.citation: J Cell Mol Med. 2007 May-Jun;11(3):521-30
references.pmid: 17635643
references.citation: Hum Gene Ther. 1998 Oct 10;9(15):2197-205
references.pmid: 9794204
references.citation: Mol Cell Biol. 2005 Mar;25(6):2085-94
references.pmid: 15743807
references.citation: PLoS Comput Biol. 2006 Nov 24;2(11):e157
references.pmid: 17166054
references.citation: Science. 2000 Apr 28;288(5466):669-72
references.pmid: 10784449
references.citation: Exp Hematol. 2006 Oct;34(10):1333-43
references.pmid: 16982326
references.citation: Nat Med. 2006 Mar;12(3):348-53
references.pmid: 16491086
references.citation: Nat Protoc. 2007;2(12):3146-52
references.pmid: 18079714
references.citation: FEBS Lett. 2005 Nov 7;579(27):6205-9
references.pmid: 16243318
references.citation: Methods. 2002 Oct;28(2):227-36
references.pmid: 12413421
references.citation: Mol Ther. 2005 Dec;12(6):1148-56
references.pmid: 16150650
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):89-93
references.pmid: 1729724
references.citation: J Virol. 2000 Feb;74(3):1286-95
references.pmid: 10627539
references.citation: Cell Cycle. 2006 Jun;5(12):1275-80
references.pmid: 16775431
references.citation: Cell. 1985 Jun;41(2):521-30
references.pmid: 2985280
references.citation: Stem Cells. 2007 Nov;25(11):2919-27
references.pmid: 17673526
references.citation: Hum Gene Ther. 2007 Sep;18(9):849-60
references.pmid: 17767401
references.citation: Blood. 1999 Nov 15;94(10):3349-57
references.pmid: 10552944
references.citation: Nat Protoc. 2007;2(12):3153-65
references.pmid: 18079715
references.citation: Blood. 1998 Jun 15;91(12):4600-7
references.pmid: 9616156
references.citation: Mol Ther. 2006 Jun;13(6):1121-32
references.pmid: 16556511
references.citation: Genetics. 1998 May;149(1):179-87
references.pmid: 9584095
references.citation: Science. 2003 Jan 24;299(5606):495
references.pmid: 12543948
references.citation: Science. 2003 Oct 17;302(5644):415-9
references.pmid: 14564000
references.citation: Mol Cell Biol. 2004 Oct;24(20):9239-47
references.pmid: 15456893
references.citation: Adv Genet. 2005;54:189-232
references.pmid: 16096013
references.citation: Genetics. 1996 Nov;144(3):1087-95
references.pmid: 8913752
references.citation: Science. 2003 May 2;300(5620):763
references.pmid: 12730593
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4626-30
references.pmid: 1905011
references.citation: Mol Ther. 2003 Jul;8(1):108-17
references.pmid: 12842434
references.citation: N Engl J Med. 2001 Mar 22;344(12):881-8
references.pmid: 11259721
references.citation: Nat Protoc. 2008;3(12):1932-40
references.pmid: 19180077